Cargando…
Expression of Receptors for SARS-CoV-2 in the Gut of Patients with Inflammatory Bowel Disease
Autores principales: | Monteleone, Giovanni, Franzè, Eleonora, Laudisi, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366141/ https://www.ncbi.nlm.nih.gov/pubmed/32482915 http://dx.doi.org/10.5009/gnl20112 |
Ejemplares similares
-
Lesional Accumulation of CD163-Expressing Cells in the Gut of Patients with Inflammatory Bowel Disease
por: Franzè, Eleonora, et al.
Publicado: (2013) -
Update on SARS-CoV-2 vaccination of patients with inflammatory bowel disease: what clinicians need to know
por: Lee, Yoo Jin, et al.
Publicado: (2022) -
Impact of Food Additives on Gut Homeostasis
por: Laudisi, Federica, et al.
Publicado: (2019) -
Impact of Sars‐CoV‐2 pandemic on psoriatic patients
por: Biondi, Gabriele, et al.
Publicado: (2022) -
Interleukin-34 Enhances the Tumor Promoting Function of Colorectal Cancer-Associated Fibroblasts
por: Franzè, Eleonora, et al.
Publicado: (2020)